Oct 28, 2024
Resalis Therapeutics Gains Strategic Equity Investment from Sanofi
Press Releases
Feb 1, 2024
Resalis Therapeutics Appoints Almut Nitsche as Chief Medical and Development Officer
Jan 4, 2024
Resalis Therapeutics Raises €10 Million Series A to Complete First Clinical Trial for RES-010 in Obesity
Feb 22, 2023
Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
